Potentiation of goitrogenic action of sulfonamide by trimethoprim.
D000311:Adrenal Glands / Q000033:anatomy & histology; D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology*; D004105:Diiodotyrosine / Q000096:biosynthesis; D004357:Drug Synergism; D005493:Folic Acid Antagonists / Q000494:pharmacology*; D006042:Goiter / Q000139:chemically induced*; D007455:Iodine / Q000378:metabolism; D007456:Iodine Isotopes; D008297:Male; D007470:Monoiodotyrosine / Q000096:biosynthesis; D009929:Organ Size; D010902:Pituitary Gland / Q000033:anatomy & histology; D011743:Pyrimidines / Q000494:pharmacology*; D051381:Rats; D013449:Sulfonamides / Q000009:adverse effects / Q000494:pharmacology*; D013737:Testis / Q000033:anatomy & histology; D013961:Thyroid Gland / Q000033:anatomy & histology / Q000187:drug effects* / Q000378:metabolism; D013974:Thyroxine / Q000096:biosynthesis; D014284:Triiodothyronine / Q000096:biosynthesis; D014295:Trimethoprim / Q000009:adverse effects / Q000494:pharmacology
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D007456:Iodine Isotopes; D011743:Pyrimidines; D013449:Sulfonamides; D014284:Triiodothyronine; D004105:Diiodotyrosine; D007455:Iodine; D014295:Trimethoprim; D007470:Monoiodotyrosine; D013974:Thyroxine